** Medical device maker Nevro Corp's shares NVRO.N rise 14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5% to $88.22
** Globus Medical to acquire all shares of Nevro in an all-cash transaction, representing a total equity value of ~$250 million
** Deal offers $5.85 per share for each share of Nevro Corp, a premium of 16.5% to NVRO's last close
** Deal is expected to close late in Q2 2025
** In the last 12 months, GMED up 58.88%, while NVRO has fallen 60.78%
(Reporting by Siddhi Mahatole)
((siddhiprabhanjan.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。